Malone CS et al. |
B29 gene silencing in pituitary cells is regulated by its 3' enhancer. |
2006 |
J. Mol. Biol. |
pmid:16920149
|
Lee JH et al. |
Structural and functional studies of the yeast class II Hda1 histone deacetylase complex. |
2009 |
J. Mol. Biol. |
pmid:19573535
|
Sawarkar R et al. |
Histone deacetylases regulate multicellular development in the social amoeba Dictyostelium discoideum. |
2009 |
J. Mol. Biol. |
pmid:19576222
|
Lopez-Atalaya JP et al. |
Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. |
2012 |
J. Med. Genet. |
pmid:21984751
|
Patel V et al. |
Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. |
2009 |
J. Med. Chem. |
pmid:19317450
|
Olsen CA and Ghadiri MR |
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. |
2009 |
J. Med. Chem. |
pmid:19705846
|
Trapp J et al. |
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. |
2006 |
J. Med. Chem. |
pmid:17149860
|
Liu T et al. |
Design and synthesis of a potent histone deacetylase inhibitor. |
2007 |
J. Med. Chem. |
pmid:17419603
|
Ragno R et al. |
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies. |
2004 |
J. Med. Chem. |
pmid:14998325
|
Kim DK et al. |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14667227
|
Bergman JA et al. |
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. |
2012 |
J. Med. Chem. |
pmid:23009203
|
Remiszewski SW et al. |
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. |
2002 |
J. Med. Chem. |
pmid:11831887
|
Mai A et al. |
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity. |
2004 |
J. Med. Chem. |
pmid:14971890
|
Baud MG et al. |
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. |
2012 |
J. Med. Chem. |
pmid:22280363
|
Remiszewski SW et al. |
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). |
2003 |
J. Med. Chem. |
pmid:14521422
|
Jung M et al. |
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. |
1999 |
J. Med. Chem. |
pmid:10579829
|
He R et al. |
Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. |
2010 |
J. Med. Chem. |
pmid:20055418
|
Auzzas L et al. |
Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity. |
2010 |
J. Med. Chem. |
pmid:21073160
|
Massa S et al. |
Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogues of trichostatin A. |
1990 |
J. Med. Chem. |
pmid:2213836
|
Huber K et al. |
Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). |
2010 |
J. Med. Chem. |
pmid:20030343
|
Trunzer M et al. |
Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation. |
2009 |
J. Med. Chem. |
pmid:19108654
|
Massa S et al. |
3-(4-aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors. |
2001 |
J. Med. Chem. |
pmid:11405644
|
Yu CW et al. |
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease. |
2013 |
J. Med. Chem. |
pmid:23905680
|
Wittich S et al. |
Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. |
2002 |
J. Med. Chem. |
pmid:12109913
|
Lu Q et al. |
Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. |
2005 |
J. Med. Chem. |
pmid:16107152
|
Heltweg B et al. |
Subtype selective substrates for histone deacetylases. |
2004 |
J. Med. Chem. |
pmid:15456267
|
Paris M et al. |
Histone deacetylase inhibitors: from bench to clinic. |
2008 |
J. Med. Chem. |
pmid:18247554
|
Xiao J et al. |
Discovery, synthesis, and biological evaluation of novel SMN protein modulators. |
2011 |
J. Med. Chem. |
pmid:21819082
|
Casero RA and Woster PM |
Recent advances in the development of polyamine analogues as antitumor agents. |
2009 |
J. Med. Chem. |
pmid:19534534
|
Mai A et al. |
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. |
2002 |
J. Med. Chem. |
pmid:11960489
|
Mai A et al. |
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors. |
2006 |
J. Med. Chem. |
pmid:17004718
|
Woo SH et al. |
Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. |
2002 |
J. Med. Chem. |
pmid:12061890
|
Chen Y et al. |
A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum. |
2008 |
J. Med. Chem. |
pmid:18494463
|
Glenn MP et al. |
Antiproliferative and phenotype-transforming antitumor agents derived from cysteine. |
2004 |
J. Med. Chem. |
pmid:15163181
|
Charrier C et al. |
Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression. |
2009 |
J. Med. Chem. |
pmid:19385600
|
Mai A et al. |
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. |
2005 |
J. Med. Chem. |
pmid:15857140
|
Miller TA et al. |
Histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14613312
|
Day JA and Cohen SM |
Investigating the selectivity of metalloenzyme inhibitors. |
2013 |
J. Med. Chem. |
pmid:24074025
|
Mai A et al. |
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. |
2003 |
J. Med. Chem. |
pmid:14584932
|
Kozikowski AP et al. |
Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. |
2008 |
J. Med. Chem. |
pmid:18642892
|
Suzuki T et al. |
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. |
1999 |
J. Med. Chem. |
pmid:10425110
|
Itoh Y et al. |
Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. |
2007 |
J. Med. Chem. |
pmid:17929798
|
Neelarapu R et al. |
Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes. |
2011 |
J. Med. Chem. |
pmid:21548582
|
Suzuki T et al. |
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. |
2006 |
J. Med. Chem. |
pmid:16884291
|
Marek L et al. |
Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. |
2013 |
J. Med. Chem. |
pmid:23252603
|
Bouchain G et al. |
Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:12593661
|
Nunes MJ et al. |
Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. |
2012 |
J. Lipid Res. |
pmid:22693257
|
Clarke CJ et al. |
ATRA transcriptionally induces nSMase2 through CBP/p300-mediated histone acetylation. |
2016 |
J. Lipid Res. |
pmid:27013100
|
Reddy P |
Editorial: HDAC inhibition begets more MDSCs. |
2012 |
J. Leukoc. Biol. |
pmid:22547132
|
Rosborough BR et al. |
Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo. |
2012 |
J. Leukoc. Biol. |
pmid:22028329
|
Rossi LE et al. |
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. |
2012 |
J. Leukoc. Biol. |
pmid:22124136
|
Halili MA et al. |
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. |
2010 |
J. Leukoc. Biol. |
pmid:20200406
|
Claus R et al. |
Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression. |
2006 |
J. Leukoc. Biol. |
pmid:17000900
|
Bosisio D et al. |
Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. |
2008 |
J. Leukoc. Biol. |
pmid:18780875
|
Moldenhauer A et al. |
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. |
2004 |
J. Leukoc. Biol. |
pmid:15197237
|
Phelan MW et al. |
Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. |
1998 |
J. Lab. Clin. Med. |
pmid:9851743
|
Sung TY et al. |
Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas. |
2012 |
J. Korean Med. Sci. |
pmid:22787366
|
Jung N et al. |
Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. |
2012 |
J. Korean Med. Sci. |
pmid:22690089
|
Tran HT et al. |
Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A. |
2013 |
J. Korean Med. Sci. |
pmid:23400519
|
Russell SB et al. |
Epigenetically altered wound healing in keloid fibroblasts. |
2010 |
J. Invest. Dermatol. |
pmid:20555348
|
Tigges J et al. |
Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. |
2013 |
J. Invest. Dermatol. |
pmid:22951721
|
Markova NG et al. |
Inhibition of histone deacetylation promotes abnormal epidermal differentiation and specifically suppresses the expression of the late differentiation marker profilaggrin. |
2007 |
J. Invest. Dermatol. |
pmid:17195011
|
Johnson JL et al. |
The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure. |
2014 |
J. Invest. Dermatol. |
pmid:24594668
|
Schauber J et al. |
Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. |
2008 |
J. Invest. Dermatol. |
pmid:17943182
|
Nakazawa Y et al. |
Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. |
2013 |
J. Immunother. |
pmid:23211626
|
Lu L et al. |
Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. |
2010 |
J. Immunol. |
pmid:20304828
|
Lee KY et al. |
NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. |
2006 |
J. Immunol. |
pmid:16365456
|
Bai Y et al. |
Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. |
2005 |
J. Immunol. |
pmid:16210620
|
Gao B et al. |
Inhibition of histone deacetylase activity suppresses IFN-γ induction of tripartite motif 22 via CHIP-mediated proteasomal degradation of IRF-1. |
2013 |
J. Immunol. |
pmid:23729439
|
Grabiec AM et al. |
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. |
2010 |
J. Immunol. |
pmid:20100935
|
Bachl J et al. |
Increased transcription levels induce higher mutation rates in a hypermutating cell line. |
2001 |
J. Immunol. |
pmid:11290786
|
Gays F et al. |
The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin. |
2000 |
J. Immunol. |
pmid:10799866
|
Maës J et al. |
Chromatin remodeling at the Ig loci prior to V(D)J recombination. |
2001 |
J. Immunol. |
pmid:11441093
|
Magner WJ et al. |
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. |
2000 |
J. Immunol. |
pmid:11120829
|
Uhlenbrock F et al. |
The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. |
2014 |
J. Immunol. |
pmid:25024379
|
Thomas RM et al. |
Regulation of mouse mammary tumor virus env transcriptional activator initiated mammary tumor virus superantigen transcripts in lymphomas of SJL/J mice: role of Ikaros, demethylation, and chromatin structural change in the transcriptional activation of mammary tumor virus superantigen. |
2003 |
J. Immunol. |
pmid:12496403
|
Serrat N et al. |
The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPβ. |
2014 |
J. Immunol. |
pmid:24307736
|
Sebastián C et al. |
Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. |
2008 |
J. Immunol. |
pmid:18424709
|
Ishiguro K et al. |
Cutting edge: tubulin α functions as an adaptor in NFAT-importin β interaction. |
2011 |
J. Immunol. |
pmid:21278340
|
Northrop JK et al. |
Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. |
2008 |
J. Immunol. |
pmid:18606637
|
Schmeck B et al. |
Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. |
2008 |
J. Immunol. |
pmid:18606645
|
Zabel MD et al. |
Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. |
1999 |
J. Immunol. |
pmid:10453011
|
Zhang Y et al. |
Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. |
2008 |
J. Immunol. |
pmid:18097041
|
Laribee RN and Klemsz MJ |
Loss of PU.1 expression following inhibition of histone deacetylases. |
2001 |
J. Immunol. |
pmid:11673528
|
Mataki H et al. |
Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. |
2015 |
J. Hum. Genet. |
pmid:25518741
|
Xu S et al. |
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. |
2005 |
J. Hum. Genet. |
pmid:15824892
|
Yoshioka H et al. |
A novel in vitro system for analyzing parental allele-specific histone acetylation in genomic imprinting. |
2001 |
J. Hum. Genet. |
pmid:11721881
|
Huang H et al. |
Expression of P53, P21 in human lung adenocarcinoma A549 cell strains under hypoxia conditions and the effect of TSA on their expression. |
2003 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15015635
|
Li C et al. |
Effect and comparison of sodium butyrate and trichostatin A on the proliferation/differentiation of K562. |
2003 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:14526425
|
He J et al. |
Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. |
2006 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:17219959
|
Liu H et al. |
Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro. |
2006 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:17219960
|
Sun C et al. |
Anticancer activities of trichostatin A on maligant lymphoid cells. |
2006 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:17219961
|
Hong Z et al. |
Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells. |
2009 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:19662360
|
Li X et al. |
Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells. |
2004 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15791844
|
Li C et al. |
Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression. |
2009 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:19821084
|
Marquardt JU et al. |
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. |
2015 |
J. Hepatol. |
pmid:25937435
|
Herold C et al. |
The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. |
2002 |
J. Hepatol. |
pmid:11830335
|
Papeleu P et al. |
Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. |
2003 |
J. Hepatol. |
pmid:12927923
|
Zhang C et al. |
Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. |
2010 |
J. Hepatol. |
pmid:20675009
|
Chiba T et al. |
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. |
2004 |
J. Hepatol. |
pmid:15336447
|